drugset / Trial / NCT00145522
Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal Women
RandomizedParallel-groupOpen-labelTreatment
Summary
This study is to evaluate the effects of continuously combined 17b-estradiol/dydrogesterone in comparison with tibolone on the breast metabolic markers, in particular the total insulin-like growth factor-1 (IGF-1), in postmenopausal women.
Timeline
- Start
- 2005-11
- Primary completion
- 2009-03
- Completion
- 2009-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 17ß-estradiol | Unknown | 1 mg | — |
| Subject | Dydrogesterone | Other / unclassified | 5 mg | — |
| Comparator | Tibolone | Other / unclassified | 2.5 mg | — |
Indications
No indication recorded.